Exercise Thallium-201 Scintigraphy and Prognosis in Typical Angina Pectoris and Negative Exercise Electrocardiography
Overview
Affiliations
Patients with a history of typical angina but negative exercise electrocardiography represent a subgroup with an intermediate likelihood of having coronary artery disease and future cardiac events. A retrospective study of the prognostic utility of stress-redistribution thallium-201 scintigraphy was performed in 190 such patients. A second group of 203 patients with typical angina and a positive exercise electrocardiogram were analyzed for comparative scintigraphic purposes. The cardiac event rate for the 144 negative exercise electrocardiogram patients with normal thallium results was 5 vs 15% in the 46 patients with abnormal thallium results (p = 0.01). These patients were further stratified into high (14 to 18%), intermediate (9%) and low (less than 2%) risk groups for future cardiac events based on combining the thallium results with the percentage of maximal predicted heart rate achieved. A multivariate analysis revealed that an abnormal thallium result was the only significant correlate of future cardiac events. Mechanisms responsible for the discordant finding of a negative exercise electrocardiogram in patients with typical angina include (1) false-positive angina symptomatology in low prevalence coronary artery disease groups in whom the thallium test is negative, and (2) "electrocardiographically silent" ischemia in patients in whom the thallium test is positive. These findings reveal that thallium stress-redistribution scintigraphy can be used to stratify 1-year prognosis in this subgroup of patients with typical angina and negative exercise electrocardiograms.
Yield of downstream tests after exercise treadmill testing: a prospective cohort study.
Christman M, Bittencourt M, Hulten E, Saksena E, Hainer J, Skali H J Am Coll Cardiol. 2014; 63(13):1264-1274.
PMID: 24509269 PMC: 4033667. DOI: 10.1016/j.jacc.2013.11.052.
Navare S, Mather J, Shaw L, Fowler M, Heller G J Nucl Cardiol. 2004; 11(5):551-61.
PMID: 15472640 DOI: 10.1016/j.nuclcard.2004.06.128.
Is a revision of the "nuclear cardiology warranty" in order?.
Thomas G, Miyamoto M J Nucl Cardiol. 2003; 10(3):329-32.
PMID: 12794633 DOI: 10.1016/s1071-3581(03)00439-2.
Mattera J, Arain S, Sinusas A, Finta L, Wackers F J Nucl Cardiol. 1998; 5(5):498-506.
PMID: 9796897 DOI: 10.1016/s1071-3581(98)90181-7.
Outcome of medical versus invasive treatment strategies for non-high-risk ischemic heart disease.
OKeefe Jr J, Bateman T, Ligon R, Case J, Cullom J, Barnhart C J Nucl Cardiol. 1998; 5(1):28-33.
PMID: 9504870 DOI: 10.1016/s1071-3581(98)80007-x.